Related Experiment Video
Updated: Jul 13, 2026

Methods for Acute and Subacute Murine Hindlimb Ischemia
Published on: June 21, 2016
Network Meta-analysis of Randomised Controlled Trials Comparing the Outcomes of Different Endovascular
Shivshankar Thanigaimani1, David Sun2, Usama Ahmad3
1Queensland Research Centre for Peripheral Vascular Disease (QRC-PVD), College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia; Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, Queensland, Australia.
Insights
Current evidence does not show that drug-coated balloons, stents, or atherectomy are superior to plain balloon angioplasty for treating chronic limb-threatening ischemia. Larger trials are needed to determine the best endovascular revascularization strategy to prevent amputation and death.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Chronic limb-threatening ischemia (CLTI) is a severe condition requiring effective revascularization.
- Endovascular procedures are a common treatment modality for CLTI.
- Comparing the efficacy of various endovascular techniques is crucial for optimal patient outcomes.
Purpose of the Study:
- To compare the effectiveness of different endovascular revascularization procedures for CLTI.
- To determine if drug-coated balloons (DCB), bare metal stents (BMS), drug-coated stents (DCS), or atherectomy are superior to plain balloon angioplasty (PBA).
Main Methods:
- A network meta-analysis (NMA) of randomized controlled trials (RCTs) was conducted.
- Searched PubMed and Cochrane Central Register for RCTs up to March 14, 2023.
- Primary outcomes were major amputation and death; risk of bias was assessed using the Cochrane tool.
Main Results:
- Eleven trials included 2,655 participants with CLTI.
- No endovascular strategy significantly reduced major amputation or death compared to PBA.
- GRADE certainty of evidence varied from moderate (DCB) to very low (DCS) for amputation outcomes versus PBA.
Conclusions:
- Current RCT evidence does not support the superiority of BMS, DCB, DCS, or atherectomy over PBA for preventing major amputation and death in CLTI patients.
- Larger comparative RCTs are necessary to identify the optimal endovascular revascularization strategy for CLTI.
Objective:
The aim of this study was to compare the efficacy of different endovascular revascularisation procedures for treating chronic limb threatening ischaemia (CLTI) using network meta-analysis (NMA).
Data Sources:
The databases PubMed and Cochrane Central Register for Controlled Trials were searched on 14 March 2023.
Review Methods:
A NMA of randomised controlled trials (RCTs) reporting the efficacy of different endovascular revascularisation techniques for treating CLTI was performed according to PRISMA guidelines. The primary and secondary outcomes were major amputation and death, respectively. Random effects models were developed and the results were presented using surface under the cumulative ranking curve plots and forest plots. A p value of ≤ .050 was considered statistically significant. The Cochrane collaborative tool was used to assess risk of bias.
Results:
A total of 2 655 participants of whom 94.8% had CLTI were included. Eleven trials compared plain balloon angioplasty (PBA) vs. drug coated balloon (DCB) angioplasty (n = 1 771), five trials compared bare metal stent (BMS) vs. drug coated stent (DCS) (n = 466), three trials compared atherectomy vs. DCB (n = 194), two trials compared PBA vs. BMS (n = 70), one trial compared PBA vs. atherectomy (n = 50), and one trial compared BMS vs. DCB (n = 104). None of the revascularisation strategies significantly reduced the risk of major amputation or death compared with PBA. Using the network estimates, GRADE certainty of evidence for improvement in major amputation outcomes for DCB was moderate, for atherectomy and BMS was low, and for DCS was very low compared with PBA. Risk of bias was low in 16 trials, of some concerns in six trials, and high in one trial, respectively.
Conclusion:
There is no current evidence from RCTs to reliably conclude that BMS, DCB, DCS, or atherectomy are superior to PBA in preventing major amputation and death in patients with CLTI. Larger comparative RCTs are needed to identify the best endovascular revascularisation strategy.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care

